Kumar R, Anderson J P, Park J H. "Method for the Synthesis of 5-[(2E)-1-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-2-(methoxyimino)ethyl]-N,N-diethylthiophene-2-sulfonamide" [P]. US Patent, US 10289947 B2, 2025-06-05.
发明人林芳,唐晓军,徐明华. "A Process for Preparing High-Purity 5-[(2E)-1-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-2-(methoxyimino)ethyl]-N,N-diethylthiophene-2-sulfonamide" [P]. 中国发明专利, 专利号 CN 115380521 B, 授权公告日 2024-03-09.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2020, 1049, (11), 8554-8568.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2013, 2127, 9308-9322.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 5-[(2E)-1-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-2-(methoxyimino)ethyl]-N,N-diethylthiophene-2-sulfonamide Using HRMS and NMR". Environ. Sci. Technol., 2020, 2062, (3), 428-440.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2010, 125, (3), 7891-7895.